Docetaxel and Prednisone

DRUG2 trials

Sponsors

Northwestern University, Canadian Cancer Trials Group

Conditions

PROSTATE CANCERProstate Cancer

Phase 2

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

WithdrawnNCT01087580

Northwestern UniversityPROSTATE CANCER

Start: 2011-03-31End: 2011-07-31Updated: 2017-03-03

Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer

CompletedNCT01619813

Canadian Cancer Trials GroupProstate Cancer

Start: 2012-12-14End: 2016-05-20Updated: 2023-08-04

Related Papers

A randomized phase II study of pelareorep (REO) plus docetaxel vs. docetaxel alone in patients with metastatic castration resistant prostate cancer (mCRPC): Canadian Cancer Trials Group study IND 209.

Journal of Clinical Oncology2017-05-201 citations